title: 10 questions about temozolomide and the treatment of brain tumors.
authors.affiliation: Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA.
authors.forename: Amy A
authors.initials: AA
authors.lastname: Pruitt
authors.forename: Myrna R
authors.initials: MR
authors.lastname: Rosenfeld
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003606:Dacarbazine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D000077204:Temozolomide
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide